According to the institute, about one million and forty-eight thousand residents of Germany had received the vaccination as of Friday, which is equivalent to 1.26 percent of the population in light of the difficult weeks that the country is going through.
Over the course of Friday, about 80,000 people were vaccinated, and the vaccination centers informed the institute. It is likely that other names will be added to this number due to the delay in reporting some cases of vaccination that have been completed.
In order to get complete protection from the virus, it is necessary to vaccinate a person with a second dose about three weeks after the first.
The numbers available to German federal state authorities could be much higher at the individual state level than those reported by the Robert Koch Institute, as reports are sometimes filed with the institute at a relatively late time.
About half of those vaccinated have been vaccinated so far due to the necessity of professional work, according to what the institute says, and these can be, for example, doctors and nurses who were vaccinated due to the presence of great risks due to exposure to infection during work, in addition to workers in the nursing home. Most of the remaining cases were vaccinated on the basis of their advanced age or elderly care residents.
India begins vaccination
On Saturday, India began a vaccination campaign against the emerging corona virus for its 1.3 billion people. The second most populous country in the world intends to vaccinate 300 million people, equivalent to the population of the United States, by next July as part of one of the largest vaccination campaigns in the world.
A local vaccine in India
The campaign uses two vaccines: Covaxine, produced by Barrat Biotech, the Indian Council of Medical Research, and Cofishield, a version developed by AstraZeneca and the University of Oxford. The vaccines, produced by the Serum Institute of India, were approved “urgently” in early January.
30 million medical personnel and the most vulnerable to the epidemic will be the first to receive the vaccine, followed by about 270 million over the age of fifty or those who are very vulnerable to the disease in the country that recorded the second highest infection rate in the world, with more than 10 million.
UAE / A.S. (dpa, fb)